Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06405503

Impact of Primary Language on Treatment and Outcomes in Inflammatory Bowel Disease

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
206 (estimated)
Sponsor
University of Texas at Austin · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A thorough discussion of treatment options to manage inflammatory bowel disease (IBD), including the risks and benefits of each class of medication, can be a complex discussion and time consuming. Having to use a translator adds an additional layer of time and complexity to these discussions as well as potential misunderstanding. Further, in addition to language, cultural differences can also play into treatment acceptance. This study aims to determine the impact of primary language on the selection of treatment for IBD and on disease outcomes.

Conditions

Interventions

TypeNameDescription
OTHERNO INTERVENTIONNO INTERVENTION - OBSERVATIONAL ONLY

Timeline

Start date
2024-06-01
Primary completion
2025-06-30
Completion
2025-06-30
First posted
2024-05-08
Last updated
2024-05-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06405503. Inclusion in this directory is not an endorsement.